RAB3IP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.942200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.817800E-01
Normal-vs-Stage2
4.180200E-01
Normal-vs-Stage3
2.636400E-01
Normal-vs-Stage4
5.216400E-01
Stage1-vs-Stage2
1.039560E-01
Stage1-vs-Stage3
1.233910E-02
Stage1-vs-Stage4
3.024200E-02
Stage2-vs-Stage3
2.945400E-01
Stage2-vs-Stage4
6.732200E-01
Stage3-vs-Stage4
3.468000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.149800E-01
Normal-vs-AfricanAmerican
8.834400E-01
Normal-vs-Asian
8.991000E-01
Caucasian-vs-AfricanAmerican
4.728600E-01
Caucasian-vs-Asian
7.191400E-01
AfricanAmerican-vs-Asian
9.821200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.367800E-01
Normal-vs-Female
5.538800E-01
Male-vs-Female
1.082390E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.878400E-01
Normal-vs-Age(41-60Yrs)
9.277200E-01
Normal-vs-Age(61-80Yrs)
2.650400E-01
Normal-vs-Age(81-100Yrs)
4.724400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.421000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.665600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.657900E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.385940E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.775400E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.748200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.571000E-01
Normal-vs-Daily Drinker
4.992400E-01
Normal-vs-Weekly Drinker
4.111000E-01
Normal-vs-Occasional Drinker
9.161200E-01
Normal-vs-Social Drinker
3.784000E-01
Non Drinker-vs-Daily Drinker
5.615400E-01
Non Drinker-vs-Weekly Drinker
1.664420E-01
Non Drinker-vs-Occasional Drinker
1.103150E-01
Non Drinker-vs-Social Drinker
6.625000E-01
Daily Drinker-vs-Weekly Drinker
3.868200E-01
Daily Drinker-vs-Occasional Drinker
7.180300E-02
Daily Drinker-vs-Social Drinker
3.875200E-01
Weekly Drinker-vs-Occasional Drinker
3.365600E-02
Weekly Drinker-vs-Social Drinker
1.514250E-01
Occasional Drinker-vs-Social Drinker
1.855640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.36669997541361E-09
Normal-vs-Grade 2
<1E-12
Normal-vs-Grade 3
1.62447832963153E-12
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.162400E-02
Grade 1-vs-Grade 3
5.487700E-02
Grade 1-vs-Grade 4
1.36669997541361E-09
Grade 2-vs-Grade 3
5.565000E-01
Grade 2-vs-Grade 4
<1E-12
Grade 3-vs-Grade 4
1.62447832963153E-12
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.208200E-01
Normal-vs-NonDiabetic
5.629200E-01
Diabetic-vs-NonDiabetic
1.190770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.918000E-01
Normal-vs-NoPancreatitis
5.233200E-01
Pancreatitis-vs-NoPancreatitis
4.367800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.447400E-01
Normal-vs-N1
3.209600E-01
N0-vs-N1
4.011400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.439400E-01
Normal-vs-TP53-NonMutant
9.760600E-01
TP53-Mutant-vs-TP53-NonMutant
5.198200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
